WALTHAM, Mass.--(BUSINESS WIRE)--
NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N. Gozani
M.D., Ph.D., President and Chief Executive Officer, is scheduled to
speak at the 8th annual LD Micro Main Event at the Luxe
Sunset Bel Air Hotel in Los Angeles, CA on December 3, 2015. Dr. Gozani
intends to provide an update on the Company's business activities
including the Quell® Wearable Pain Relief device.
NeuroMetrix's presentation is scheduled for Thursday, December 3, 2015,
at 7:30 a.m. Pacific Time, 10:30 a.m. Eastern Time. A live audio webcast
will be available on the investor relations section of the corporate
website - http://www.NeuroMetrix.com/.
This webcast will be archived after the live event.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
About LD Micro
LD Micro is an investment newsletter firm that focuses on finding
undervalued companies in the micro-cap space. Since 2002, the firm has
published reports on select companies throughout the year. The firm also
hosts the LD Micro Invitational in June. It is a non-registered
investment advisor. For more information, please contact 408-457-1042 or
visit www.ldmicro.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151124005214/en/
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
News Provided by Acquire Media
